Perhaps long-term NMDAR antagonism might restore KCC2 levels in peritumoral neurons [40], which would change GABA from a functionally excitatory back to an inhibitory neurotransmitter in the glioma microenvironment. This evidence concerns the gene SLC12A5 and central nervous system cancer.